Clinical spectrum of and outcomes for Indian children with deficiency of adenosine deaminase 2 (DADA2): a multicentric study
Sathish Kumar(Christian Medical College, Vellore), Athimalaipet V Ramanan(At Bristol), Narendra Kumar Bagri(All India Institute of Medical Sciences), Manisha Jana(All India Institute of Medical Sciences), Amiya Ranjan Nayak(All India Institute of Medical Sciences), Anu Punnen(Christian Medical College, Vellore), Neerja Gupta(All India Institute of Medical Sciences), Lokesh Lingappa(Rainbow Children's Hospital), Priyanka Naranje(All India Institute of Medical Sciences), Pankaj Hari(Indian Council of Medical Research), Pratap Kumar Patra(Post Graduate Institute of Medical Education and Research), Aditya Gupta(All India Institute of Medical Sciences), Jyoti Sharma(All India Institute of Medical Sciences), Samantha Cheryl Kumar(Christian Medical College, Vellore), Vijay Viswanathan(Jupiter Medical Center), Chandrika Bhat(Rainbow Children's Hospital), Akagri Chugh(All India Institute of Medical Sciences), Mukul Aggarwal(All India Institute of Medical Sciences)
Cited by 1
Related Papers
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome
|Clinical Journal of the American Society of Nephrology|2010|203
Efficacy and Safety of Tacrolimus Versus Cyclosporine in Children With Steroid-Resistant Nephrotic Syndrome: A Randomized Controlled Trial
|American Journal of Kidney Diseases|2009|176
Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome
|American Journal of Kidney Diseases|2003|140